ASHLEY MEADOWS: Open Payments
NPI 1700539418 · GREENDALE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,328 in 54 payments from 18 companies in 2025. Trend: 2023 $1,310 · 2024 $1,403 · 2025 $1,328
Food & beverage: $1,301Education: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $320 |
| Alkermes, Inc. | 9 | $271 |
| Janssen Pharmaceuticals, Inc | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 6 | $101 |
| Vanda Pharmaceuticals Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Corium, LLC | 3 | $49 |
| Exact Sciences Corporation | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
Products named: VRAYLAR, ARISTADA, INVEGA SUSTENNA, LYBALVI, FANAPT, REXULTI, COBENFY, Azstarys.
Industry payments across IN — which companies pay providers there.
